These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35266989)

  • 1. Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk.
    Shu X; Chen Z; Long J; Guo X; Yang Y; Qu C; Ahn YO; Cai Q; Casey G; Gruber SB; Huyghe JR; Jee SH; Jenkins MA; Jia WH; Jung KJ; Kamatani Y; Kim DH; Kim J; Kweon SS; Le Marchand L; Matsuda K; Matsuo K; Newcomb PA; Oh JH; Ose J; Oze I; Pai RK; Pan ZZ; Pharoah PDP; Playdon MC; Ren ZF; Schoen RE; Shin A; Shin MH; Shu XO; Sun X; Tangen CM; Tanikawa C; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Wolk A; Woods MO; Wu AH; Peters U; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1216-1226. PubMed ID: 35266989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of blood metabolites associated with colorectal cancer risk.
    Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W
    Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk.
    Shu X; Zheng W; Yu D; Li HL; Lan Q; Yang G; Cai H; Ma X; Rothman N; Gao YT; Jia W; Xiang YB; Shu XO
    Int J Cancer; 2018 Nov; 143(9):2161-2167. PubMed ID: 29717485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
    Vantaku V; Donepudi SR; Piyarathna DWB; Amara CS; Ambati CR; Tang W; Putluri V; Chandrashekar DS; Varambally S; Terris MK; Davies K; Ambs S; Bollag R; Apolo AB; Sreekumar A; Putluri N
    Cancer; 2019 Mar; 125(6):921-932. PubMed ID: 30602056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese.
    Abe M; Ito H; Oze I; Nomura M; Ogawa Y; Matsuo K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2481-2492. PubMed ID: 28849422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic-Metabolomic Associations Support the Role of
    Lains I; Zhu S; Han X; Chung W; Yuan Q; Kelly RS; Gil JQ; Katz R; Nigalye A; Kim IK; Miller JB; Carreira IM; Silva R; Vavvas DG; Miller JW; Lasky-Su J; Liang L; Husain D
    Ophthalmol Sci; 2021 Mar; 1(1):. PubMed ID: 34382031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct metabolic signature of human colorectal cancer with prognostic potential.
    Qiu Y; Cai G; Zhou B; Li D; Zhao A; Xie G; Li H; Cai S; Xie D; Huang C; Ge W; Zhou Z; Xu LX; Jia W; Zheng S; Yen Y; Jia W
    Clin Cancer Res; 2014 Apr; 20(8):2136-46. PubMed ID: 24526730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
    Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in circTUBB interacting with smoking can enhance colorectal cancer risk.
    Zhang K; Li S; Gu D; Xu K; Zheng R; Xin J; Meng Y; Ben S; Chu H; Zhang Z; Shu Y; Du M; Liu L; Wang M
    Arch Toxicol; 2020 Jan; 94(1):325-333. PubMed ID: 31797002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis.
    Zhang L; Zou H; Zhao Y; Hu C; Atanda A; Qin X; Jia P; Jiang Y; Qi Z
    BMJ Open; 2019 Dec; 9(12):e030513. PubMed ID: 31874870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links.
    Wathieu H; Issa NT; Mohandoss M; Byers SW; Dakshanamurthy S
    Comb Chem High Throughput Screen; 2017; 20(3):193-207. PubMed ID: 28024464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional metabolomics and breast cancer risk in a prospective study.
    Playdon MC; Ziegler RG; Sampson JN; Stolzenberg-Solomon R; Thompson HJ; Irwin ML; Mayne ST; Hoover RN; Moore SC
    Am J Clin Nutr; 2017 Aug; 106(2):637-649. PubMed ID: 28659298
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
    Zhong H; Liu S; Zhu J; Wu L
    Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies.
    Zhou L; Xie J; Gu EL; Huang Y; Qu Y; Xu AP; Zhu Y; Wang H
    Cytokine; 2015 Apr; 72(2):154-9. PubMed ID: 25647270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolites associated with colorectal cancer: A discovery-replication strategy.
    Geijsen AJMR; Brezina S; Keski-Rahkonen P; Baierl A; Bachleitner-Hofmann T; Bergmann MM; Boehm J; Brenner H; Chang-Claude J; van Duijnhoven FJB; Gigic B; Gumpenberger T; Hofer P; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Kok DE; Leeb G; Ulvik A; Robinot N; Ose J; Stift A; Schrotz-King P; Ulrich AB; Ueland PM; Kampman E; Scalbert A; Habermann N; Gsur A; Ulrich CM
    Int J Cancer; 2019 Sep; 145(5):1221-1231. PubMed ID: 30665271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
    Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
    Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.